Iodine

ApprovedSmall molecule

UUniversity of California, Los Angeles

Iodine is one of 76 small molecule programs targeting Amputation. It is currently in Approved.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

AmputationActive, not recruiting

HysterectomyActive, not recruiting

Breast CancerActive, not recruiting

AmputationApproved

Active, not recruiting

HysterectomyApproved

Active, not recruiting

Breast CancerPhase 2

Active, not recruiting

Competition

Competitive Landscape

2828 competitors in Breast Cancer

#DrugCompanyPhaseTrials

Iodine

UUniversity of California, Los Angeles

Approved

1 2

DATROWAY

Daiichi Sankyo

Preclinical

4 3

Zolymbus

AbbVie

Preclinical

1 4

MS Contin

HHikma Pharmaceuticals LLC

Preclinical

3 5

Acupan

YYonsei University

Preclinical

1 6

Chantix

PPrism Pharmaceuticals

Preclinical

1 7

Paracetamol

GSK

Preclinical

1 8

Motexafin Gadolinium

PPharmacyclics LLC.

Preclinical

1 9

Dextromethorphan Hydrobromide

Boehringer Ingelheim

Preclinical

1 10

Perflutren Lipid Microsphere

IImaRx Therapeutics

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Hysterectomy1 trial

Vaginal Preparation Prior to Hysterectomy

Terminated·TTriHealth Inc.·Phase 4·NCT03412734·94 enrolled

Amputation1 trial

The Amputation Surgical Site Infection Trial (ASSIT)

Completed·HHull University Teaching Hospitals NHS Trust·Phase 4·NCT02018094·160 enrolled

Efficacy1 trial

Clinical Research Study Efficacy of a Prototype Oral Rinse

Completed·CColgate Palmolive·Phase 3·NCT01021007·67 enrolled

Breast Cancer1 trial

Iodine Supplementation on Breast Cancer

Unknown status·UUniversidad Nacional Autonoma de Mexico·Phase 2·NCT03688958·120 enrolled

TED1 trial

Contrast Enhancement on Coronary Computed Tomographic Angiography

Completed·MMaastricht University Medical Center·Phase 4·NCT02462044·200 enrolled

1 more indication

Unspecified1 trial

Reducing Bacteria That Cause Tooth Decay

Completed·UUniversity of California, Los Angeles·Phase 3·NCT03062605·48 enrolled

Sources

References

[1]
ClinicalTrials.gov — 6 trial records for Iodine. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Iodine compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Iodine. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University of California, Los Angeles company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: UUniversity of California, Los Angeles

Iodine

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Hysterectomy1 trial

Amputation1 trial

Efficacy1 trial

Breast Cancer1 trial

TED1 trial

Unspecified1 trial

References

Drug Info

Quick Facts

Related News